Holigen Holdings Limited wholly-owned subsidiary of The Flowr Corporation (OTC:FLWPF)(TSXV:FLWR), has entered into a share purchase agreement dated April 19, 2022 with Akanda Corp. (NASDAQ:AKAN) and Cannahealth Limited, a wholly-owned subsidiary of Akanda.
Pursuant to the purchase agreement, the purchaser will acquire from HHL all of issued and outstanding shares of Holigen Limited, an indirect wholly-owned subsidiary of the company, together with certain inter-company receivables for aggregate consideration of approximately CA$35 million ($27.98 million). The company’s wholly-owned subsidiary, HHL, indirectly owns all of the issued and outstanding shares of RPK Biopharma Unipessoal, Lda., which owns and operates the E.U. GMP facility located in Sintra, Portugal, and the outdoor medical facility located in Aljustrel, Portugal.
